News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
891,034 Results
Type
Article (89296)
Company Profile (559)
Press Release (801152)
Multimedia
Podcasts (264)
Webinars (41)
Section
Business (267279)
Career Advice (4173)
Deals (40084)
Drug Delivery (208)
Drug Development (91951)
Employer Resources (209)
FDA (18680)
Job Trends (17526)
News (399257)
Policy (40036)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (5)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (3085)
Academic (2)
Accelerated approval (68)
ADA (51)
Adcomms (44)
Allergies (220)
Alliances (56993)
ALS (259)
Alzheimer's disease (2085)
Antibody-drug conjugate (ADC) (659)
Approvals (19148)
Artificial intelligence (1018)
ASCO (345)
Autoimmune disease (432)
Automation (73)
Bankruptcy (412)
Belgium (6)
Best Places to Work (12635)
BIO (81)
Biologics (14)
BIOSECURE Act (23)
Biosimilars (280)
BioSpace Insights (251)
Biotechnology (338)
Bispecific (1)
Bladder cancer (229)
Brain cancer (94)
Breast cancer (908)
Cancer (7263)
Cardiovascular disease (627)
Career advice (3619)
Career pathing (60)
CAR-T (420)
CDC (77)
CDMO (170)
Celiac Disease (4)
Cell therapy (1164)
Cervical cancer (61)
Clinical research (80036)
Collaboration (2644)
Commercialization (12)
Company closure (10)
Compensation (1768)
Complete response letters (123)
COVID-19 (3058)
CRISPR (137)
C-suite (1545)
Cystic fibrosis (175)
Data (9654)
Decentralized trials (3)
Denatured (103)
Depression (214)
Dermatology (129)
Diabetes (763)
Diagnostics (7790)
Digital health (80)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (512)
Drug pricing (250)
Drug shortages (39)
Duchenne muscular dystrophy (362)
Earnings (103687)
Editorial (83)
Employer branding (25)
Employer resources (179)
Events (140035)
Executive appointments (1311)
FDA (23325)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (39)
Funding (2178)
Gene editing (297)
Generative AI (102)
Gene therapy (917)
GLP-1 (1339)
Government (5600)
Grass and pollen (8)
Guidances (435)
Healthcare (21383)
Hematology (198)
HIV (113)
Huntington's disease (76)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (131)
Immunology and inflammation (395)
Immuno-oncology (140)
Indications (245)
Infectious disease (3487)
Inflammatory bowel disease (251)
Inflation Reduction Act (17)
Influenza (159)
Intellectual property (360)
Interviews (826)
IPO (18042)
IRA (61)
Job creations (5211)
Job search strategy (2879)
JPM (73)
Kidney cancer (28)
Labor market (135)
Layoffs (711)
Leadership (59)
Legal (10176)
Licensing (27)
Liver cancer (115)
Longevity (43)
Lung cancer (986)
Lymphoma (518)
Machine learning (74)
Management (70)
Manufacturing (1450)
Marketing (14)
MASH (240)
Medical affairs (3)
Medical device (15410)
Medtech (15671)
Mergers & acquisitions (23501)
Metabolic disorders (1974)
mRNA (305)
Multiple sclerosis (226)
Multispecific (1)
NASH (24)
Netherlands (5)
Neurodegenerative disease (576)
Neuropsychiatric disorders (145)
Neuroscience (4056)
Neurotech (2)
NextGen: Class of 2026 (7718)
Non-profit (5161)
Now hiring (91)
Obesity (934)
Opinion (395)
Ovarian cancer (263)
Pain (318)
Pancreatic cancer (402)
Parkinson's disease (455)
Partnered (48)
Patents (754)
Patient advocacy (1)
Patient recruitment (944)
Patient selection (1)
Peanut (73)
People (68654)
Peptides (6)
Pharmaceutical (82)
Pharmacy benefit managers (40)
Phase 1 (24702)
Phase 2 (34726)
Phase 3 (26181)
Pipeline (12175)
Policy (415)
Postmarket research (3561)
Preclinical (11057)
Press Release (72)
Prostate cancer (377)
Psychedelics (89)
Radiopharmaceuticals (410)
Rare diseases (1468)
Real estate (7473)
Recruiting (83)
Regulatory (31269)
Reports (91)
Research institute (2802)
Resumes & cover letters (656)
Rett syndrome (52)
RNA editing (33)
RSV (102)
Schizophrenia (210)
Series A (370)
Series B (269)
Service/supplier (16)
Sickle cell disease (138)
Special edition (34)
Spinal muscular atrophy (197)
Sponsored (58)
Startups (4388)
State (2)
Stomach cancer (22)
Supply chain (157)
Tariffs (105)
The Weekly (158)
Vaccines (1386)
Venture capital (160)
Weight loss (629)
Women's health (164)
Worklife (26)
Date
Today (86)
Last 7 days (718)
Last 30 days (2383)
Last 365 days (33472)
2026 (23660)
2025 (33213)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1301)
Alabama (111)
Alaska (7)
Arizona (454)
Arkansas (16)
Asia (52789)
Australia (9291)
California (15850)
Canada (4422)
China (1837)
Colorado (674)
Connecticut (707)
Delaware (490)
Europe (121756)
Florida (2413)
Georgia (520)
Hawaii (5)
Idaho (70)
Illinois (1377)
India (132)
Indiana (719)
Iowa (30)
Japan (698)
Kansas (152)
Kentucky (65)
Louisiana (68)
Maine (95)
Maryland (1904)
Massachusetts (11536)
Michigan (454)
Minnesota (875)
Mississippi (7)
Missouri (180)
Montana (37)
Nebraska (31)
Nevada (173)
New Hampshire (92)
New Jersey (4174)
New Mexico (38)
New York (4154)
North Carolina (2092)
North Dakota (11)
Northern California (8000)
Ohio (506)
Oklahoma (31)
Oregon (49)
Pennsylvania (3050)
Puerto Rico (33)
Rhode Island (56)
South America (1672)
South Carolina (96)
South Dakota (2)
Southern California (6284)
Tennessee (265)
Texas (2598)
United States (56434)
Utah (476)
Vermont (2)
Virginia (399)
Washington D.C. (88)
Washington State (1284)
West Virginia (4)
Wisconsin (179)
Wyoming (4)
There are 891,034 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
September 14, 2026
·
4 min read
Press Releases
Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
September 14, 2026
·
6 min read
Press Releases
Revelyx Bio Reports Positive Topline Phase 2 Results for YY003, a Recombinant, Ready-to-Use Liquid Botulinum Toxin Type A, in Moderate-to-Severe Glabellar Lines
September 14, 2026
·
7 min read
Press Releases
Alveus Therapeutics Initiates Phase 2 PRESERVE Trial to Evaluate ALV-100 for Chronic Weight Management
September 14, 2026
·
2 min read
C-suite
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
Analysts tentatively welcomed Novo’s new corporate rebrand—so long as it comes with a larger change to the company’s overall business strategy.
September 14, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy
September 14, 2026
·
4 min read
Press Releases
Santa Ana Bio Announces First Subjects Dosed in Phase 1 Study of SAB01 to Treat Autoimmune Inflammatory Diseases
September 14, 2026
·
2 min read
Breast cancer
AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger market
SERENA-4 was assessing AstraZeneca’s Etcamah as a first-line option for certain patients with advanced breast cancer—a setting that could have meant a $2.9 billion opportunity for the drug.
September 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
September 14, 2026
·
5 min read
Press Releases
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
September 14, 2026
·
15 min read
1 of 89,104
Next